U.S. markets closed

BioSpecifics Technologies Corp. (BSTC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
88.440.00 (0.00%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close88.44
Open88.45
Bid88.44 x 21500
Ask88.47 x 900
Day's Range88.44 - 88.48
52 Week Range42.00 - 89.15
Volume81,536
Avg. Volume109,818
Market Cap649.588M
Beta (5Y Monthly)0.27
PE Ratio (TTM)37.47
EPS (TTM)2.36
Earnings DateNov 09, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est88.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
28% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
    ACCESSWIRE

    STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

    NEW YORK, NY / ACCESSWIRE / November 20, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * BioSpecifics Technologies Corp.

  • SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – BSTC, UROV, CXO
    ACCESSWIRE

    SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – BSTC, UROV, CXO

    NEW YORK, NY / ACCESSWIRE / November 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:BioSpecifics Technologies Corp.

  • Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer
    PR Newswire

    Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer

    Endo International plc (Nasdaq: ENDP) ("Endo") today announced the expiration of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), in connection with the previously announced tender offer by Beta Acquisition Corp., a wholly-owned indirect subsidiary of Endo ("Merger Sub"), to acquire all of the outstanding shares of common stock, par value $0.001 per share (the "Shares") of BioSpecifics Technologies Corp. (Nasdaq: BSTC) ("BioSpecifics"), at a price of $88.50 per Share (the "Offer Price"), net to the holder in cash, without interest and less any applicable withholding taxes (the "Offer"). The Offer, which commenced on November 2, 2020, is being made pursuant to the previously announced Agreement and Plan of Merger, dated October 19, 2020, by and among Endo, Merger Sub and BioSpecifics (as it may be amended from time to time, the "Merger Agreement").